Pfizer quarterly revenue soars 19.7%
[BENGALURU] US drugmaker Pfizer Inc reported a 19.7 per cent rise in quarterly revenue, boosted by sales of its new treatments for cancer and its Hospira acquisition.
The company's revenue rose to US$13.01 billion in the first quarter, from US$10.86 billion a year earlier.
Net income rose to US$3.02 billion, or 49 cents per share, from US$2.38 billion, or 38 cents per share.
Pfizer and Allergan Inc walked away from their US$160 billion merger in April, citing new US Treasury rules aimed at blocking the deal's tax benefits.
REUTERS
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue
Nestle sales growth sputters on US slump, vitamin snags
Hermes Q1 sales jump 17% on strong China demand
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO